Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

February 28, 1999

Primary Completion Date

July 31, 2005

Conditions
LeukemiaLymphoma
Interventions
DRUG

aminolevulinic acid hydrochloride

Trial Locations (1)

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00054171 - Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia | Biotech Hunter | Biotech Hunter